Reply to: “Comment on ‘Bullous pemphigoid after anti–PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes’”
Journal of the American Academy of Dermatology（2020）
关键词
Autoimmune,BP,ICI,PD-1,PD-L1,blistering,bullous pemphigoid,cancer,dAE,dermatologic adverse event,immune checkpoint inhibitor,immunotherapy,nivolumab,oncodermatology,oncology,pembrolizumab,programmed death ligand-1,programmed death-1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要